Key result
Perinatal depressive symptoms are linked to worse postpartum cardiovascular health across all elevated trajectories.
Why the study?
Do elevated or worsening depressive symptom trajectories during pregnancy and postpartum reduce future cardiovascular health in women?
Cohort (n=3,934)
Yes
Do elevated or worsening depressive symptom trajectories during pregnancy and postpartum reduce future cardiovascular health in women?
Effect estimate: β=0.06
p-value: p=<0.01
Elevated depressive symptoms at any point during pregnancy or up to 2-7 years postpartum are associated with worse future cardiometabolic health, highlighting the need for long-term cardiovascular risk monitoring in this population.
Elevated depressive symptom trajectories were associated with lower CVH; leaves open whether screening or treatment improves long-term outcomes.
BACKGROUND: Individuals diagnosed with depression during pregnancy are more likely to develop cardiovascular disease (CVD) later in life. However, it remains unclear whether subclinical depressive symptoms or symptom trajectories across time are associated with indicators of cardiovascular health (CVH). Therefore, the present study evaluated the relationship between longitudinal depressive symptom trajectories beginning in pregnancy and future CVH. METHODS: This secondary analysis of the multisite prospective nuMoM2b-Heart Health Study and included participants with complete longitudinal data from early pregnancy to 2-7 years post-delivery. Participants self-reported depressive symptoms using the Edinburgh Postnatal Depression Scale (EPDS) at 6-13 weeks gestation (early pregnancy), 22-29 weeks gestation (mid- to late-pregnancy), and 2-7 years post-delivery. Latent class mixture modeling was conducted to identify longitudinal patterns of depressive symptoms across early pregnancy, mid-late pregnancy, and extended postpartum follow-up. Structural equation modeling was used to test whether EPDS trajectories were associated with latent CVH, adjusted for length of follow-up interval, pre-pregnancy BMI, gravidity, adverse pregnancy outcomes, smoking history, age, education, income, and use of psychiatric medications. RESULTS: A total of 3,934 participants (mean (M) ± standard deviation (SD) age=27.6±5.6 years) met inclusion criteria with a mean follow-up interval of 3.2±0.9 years. A 4-class model, which provided the best fit to the EPDS data (mean posterior probability across classes=0.81), produced the following trajectories: (1) stable low (n=2412; 61.1%), (2) increasing severity (n=848; 21.5%), (3) decreasing severity (n=476; 12.1%), and (4) stable high (n=212; 5.4%). Compared to the stable low group, all groups exhibited significantly lower CVH (stable high: β=0.06, p<0.01; decreasing severity: β=0.05, p=0.02; increasing severity: β=0.08 p<0.01). Pairwise comparisons among the three elevated-symptom groups revealed no significant differences in latent CVH (all ps >0.24). DISCUSSION: The longitudinal course of depressive symptoms from pregnancy to 2-7 years post-delivery varied across individuals. Compared to those with consistently low depressive symptoms, individuals with higher severity symptoms at any point all exhibited lower CVH, regardless of the specific trajectory of symptoms. These findings support a life-course perspective in which depressive symptom patterns may represent an early indicator of cardiometabolic vulnerability.
No takes yet. Share an insight, caveat, or question.
Donofry et al. (2026) conducted a cohort in Depression during pregnancy and postpartum (n=3,934). Elevated depressive symptom trajectories (stable high, increasing, or decreasing severity) vs. Stable low depressive symptoms was evaluated on Latent cardiovascular health (CVH) at 2-7 years post-delivery (β=0.06, p=<0.01). Compared to individuals with consistently low depressive symptoms, those with stable high (β=0.06, p<0.01), decreasing (β=0.05, p=0.02), or increasing (β=0.08, p<0.01) symptom severity across pregnancy and postpartum exhibited significantly lower cardiovascular health.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: